|
1
|
Sturgis EM and Miller RH: Second primary
malignancies in the head and neck cancer patient. Ann Otol Rhinol
Laryngol. 104:946–954. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rothman KJ: The effect of alcohol
consumption on risk of cancer of the head and neck. Laryngoscope.
88(Suppl 8): 51–55. 1978.PubMed/NCBI
|
|
3
|
Maier H, Dietz A, Gewelke U, Heller WD and
Weidauer H: Tobacco and alcohol and the risk of head and neck
cancer. Clin Investig. 70:320–327. 1992.PubMed/NCBI
|
|
4
|
Rothman KJ: Epidemiology of head and neck
cancer. Laryngoscope. 88:435–438. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin YS, Jen YM, Wang BB, Lee JC and Kang
BH: Epidemiology of oral cavity cancer in Taiwan with emphasis on
the role of betel nut chewing. ORL J Otorhinolaryngol Relat Spec.
67:230–236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mannarini L, Kratochvil V, Calabrese L,
Gomes Silva L, Morbini P, Betka J and Benazzo M: Human papilloma
virus (HPV) in head and neck region: Review of literature. Acta
Otorhinolaryngol Ital. 29:119–126. 2009.
|
|
7
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lacko M, Braakhuis BJ, Sturgis EM,
Boedeker CC, Suárez C, Rinaldo A, Ferlito A and Takes RP: Genetic
susceptibility to head and neck squamous cell carcinoma. Int J
Radiat Oncol Biol Phys. 89:38–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park MR, Kim SG, Cho IA, Oh D, Kang KR,
Lee SY, Moon SM, Cho SS, Yoon G, Kim CS, et al: Licochalcone-A
induces intrinsic and extrinsic apoptosis via ERK1/2 and p38
phosphorylation-mediated TRAIL expression in head and neck squamous
carcinoma FaDu cells. Food Chem Toxicol. 77:34–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fesik SW: Promoting apoptosis as a
strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Renehan AG, Booth C and Potten CS: What is
apoptosis, and why is it important? BMJ. 322:1536–1538. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan KH, Blanco-Codesido M and Molife LR:
Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev
Oncol Hematol. 90:200–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luqmani YA: Mechanisms of drug resistance
in cancer chemotherapy. Med Princ Pract. 14(Suppl 1): 35–48. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ni WJ, Ding HH and Tang LQ: Berberine as a
promising anti-diabetic nephropathy drug: An analysis of its
effects and mechanisms. Eur J Pharmacol. 760:103–112. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Z, Jiao Q, Ding J, Liu F, Liu R, Shan
L, Zeng H, Zhang J and Zhang W: Berberine induces dendritic cell
apoptosis and has therapeutic potential for rheumatoid arthritis.
Arthritis Rheum. 63:949–959. 2011. View Article : Google Scholar
|
|
16
|
Xiao HB, Sun ZL, Zhang HB and Zhang DS:
Berberine inhibits dyslipidemia in C57BL/6 mice with
lipopolysaccharide induced inflammation. Pharmacol Rep. 64:889–895.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Geng YN, Jiang JD and Kong WJ:
Antioxidant and anti-in flammatory activities of berberine in the
treatment of diabetes mellitus. Evid Based Complement Alternat Med.
2014:2892642014. View Article : Google Scholar
|
|
18
|
Tan Y, Tang Q, Hu BR and Xiang JZ:
Antioxidant properties of berberine on cultured rabbit corpus
cavernosum smooth muscle cells injured by hydrogen peroxide. Acta
Pharmacol Sin. 28:1914–1918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Zhao Y, Zhang M, Pang X, Xu J,
Kang C, Li M, Zhang C, Zhang Z, Zhang Y, et al: Structural changes
of gut microbiota during berberine-mediated prevention of obesity
and insulin resistance in high-fat diet-fed rats. PLoS One.
7:e425292012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim S, Choi JH, Kim JB, Nam SJ, Yang JH,
Kim JH and Lee JE: Berberine suppresses TNF-alpha-induced MMP-9 and
cell invasion through inhibition of AP-1 activity in MDA-MB-231
human breast cancer cells. Molecules. 13:2975–2985. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Cao B, Liu X, Fu X, Xiong Z, Chen L,
Sartor O, Dong Y and Zhang H: Berberine suppresses androgen
receptor signaling in prostate cancer. Mol Cancer Ther.
10:1346–1356. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin JP, Yang JS, Chang NW, Chiu TH, Su CC,
Lu KW, Ho YT, Yeh CC, Mei-Dueyang, Lin HJ, et al: GADD153 mediates
berberine-induced apoptosis in human cervical cancer Ca ski cells.
Anticancer Res. 27:3379–3386. 2007.PubMed/NCBI
|
|
23
|
Lin JP, Yang JS, Wu CC, Lin SS, Hsieh WT,
Lin ML, Yu FS, Yu CS, Chen GW, Chang YH, et al: Berberine induced
down-regulation of matrix metalloproteinase-1, -2 and -9 in human
gastric cancer cells (SNU-5) in vitro. In Vivo. 22:223–230.
2008.PubMed/NCBI
|
|
24
|
Kim JS, Oh D, Yim MJ, Park JJ, Kang KR,
Cho IA, Moon SM, Oh JS, You JS, Kim CS, et al: Berberine induces
FasL-related apoptosis through p38 activation in KB human oral
cancer cells. Oncol Rep. 33:1775–1782. 2015.PubMed/NCBI
|
|
25
|
Kuo CL, Chi CW and Liu TY: Modulation of
apoptosis by berberine through inhibition of cyclooxygenase-2 and
Mcl-1 expression in oral cancer cells. In Vivo. 19:247–252.
2005.PubMed/NCBI
|
|
26
|
Jin P, Zhang C and Li N: Berberine
exhibits antitumor effects in human ovarian cancer cells.
Anticancer Agents Med Chem. 15:511–516. 2015. View Article : Google Scholar
|
|
27
|
Kim JS, Ellman MB, An HS, Yan D, van
Wijnen AJ, Murphy G, Hoskin DW and Im HJ: Lactoferricin mediates
anabolic and anti-catabolic effects in the intervertebral disc. J
Cell Physiol. 227:1512–1520. 2012. View Article : Google Scholar
|
|
28
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
29
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Silverman S Jr: Oral cancer: Complications
of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
88:122–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Letasiová S, Jantová S, Cipák L and
Múcková M: Berberine-anti-proliferative activity in vitro and
induction of apoptosis/necrosis of the U937 and B16 cells. Cancer
Lett. 239:254–262. 2006. View Article : Google Scholar
|
|
32
|
Oberhammer FA, Hochegger K, Fröschl G,
Tiefenbacher R and Pavelka M: Chromatin condensation during
apoptosis is accompanied by degradation of lamin A+B, without
enhanced activation of cdc2 kinase. J Cell Biol. 126:827–837. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hensley P, Mishra M and Kyprianou N:
Targeting caspases in cancer therapeutics. Biol Chem. 394:831–843.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ikner A and Ashkenazi A: TWEAK induces
apoptosis through a death-signaling complex comprising
receptor-interacting protein 1 (RIP1), Fas-associated death domain
(FADD), and caspase-8. J Biol Chem. 286:21546–21554. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Zhu H, Xu CJ and Yuan J: Cleavage of
BID by caspase 8 mediates the mitochondrial damage in the Fas
pathway of apoptosis. Cell. 94:491–501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fischer B, Coelho D, Dufour P, Bergerat
JP, Denis JM, Gueulette J and Bischoff P: Caspase 8-mediated
cleavage of the pro-apoptotic BCL-2 family member BID in
p53-dependent apoptosis. Biochem Biophys Res Commun. 306:516–522.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu J, Xiong L, Yu B and Wu J: Apoptosis
induced by a new member of saponin family is mediated through
caspase-8-dependent cleavage of Bcl-2. Mol Pharmacol. 68:1831–1838.
2005.PubMed/NCBI
|
|
38
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang P, Yu J and Zhang L: The nuclear
function of p53 is required for PUMA-mediated apoptosis induced by
DNA damage. Proc Natl Acad Sci USA. 104:4054–4059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang N, Zhu M, Wang X, Tan HY, Tsao SW and
Feng Y: Berberine-induced tumor suppressor p53 up-regulation gets
involved in the regulatory network of miR-23a in hepatocellular
carcinoma. Biochim Biophys Acta. 1839:849–857. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Liu Q, Liu Z, Li B, Sun Z, Zhou H,
Zhang X, Gong Y and Shao C: Berberine, a genotoxic alkaloid,
induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat
Res. 734:20–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu JX, Zhang DG, Zheng JN and Pei DS:
Rap2a is a novel target gene of p53 and regulates cancer cell
migration and invasion. Cell Signal. 27:1198–1207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Boudreau HE, Casterline BW, Burke DJ and
Leto TL: Wild-type and mutant p53 differentially regulate NADPH
oxidase 4 in TGF-β-mediated migration of human lung and breast
epithelial cells. Br J Cancer. 110:2569–2582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Momota H, Narita Y, Matsushita Y, Miyakita
Y and Shibui S: p53 abnormality and tumor invasion in patients with
malignant astrocytoma. Brain Tumor Pathol. 27:95–101. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Muller PA, Caswell PT, Doyle B, Iwanicki
MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL,
Gosselin P, et al: Mutant p53 drives invasion by promoting integrin
recycling. Cell. 139:1327–1341. 2009. View Article : Google Scholar
|
|
47
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tomao F, Papa A, Rossi L, Zaccarelli E,
Caruso D, Zoratto F, Benedetti Panici P and Tomao S: Angiogenesis
and anti-angiogenic agents in cervical cancer. Onco Targets Ther.
7:2237–2248. 2014. View Article : Google Scholar
|
|
49
|
Mukhopadhyay D, Tsiokas L and Sukhatme VP:
Wild-type p53 and v-Src exert opposing influences on human vascular
endothelial growth factor gene expression. Cancer Res.
55:6161–6165. 1995.PubMed/NCBI
|
|
50
|
Qin G, Kishore R, Dolan CM, Silver M,
Wecker A, Luedemann CN, Thorne T, Hanley A, Curry C, Heyd L, et al:
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent
transcriptional control of VEGF. Proc Natl Acad Sci USA.
103:11015–11020. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ehrenfeld P, Conejeros I, Pavicic MF,
Matus CE, Gonzalez CB, Quest AF, Bhoola KD, Poblete MT, Burgos RA
and Figueroa CD: Activation of kinin B1 receptor increases the
release of metalloproteases-2 and -9 from both estrogen-sensitive
and -insensitive breast cancer cells. Cancer Lett. 301:106–118.
2011. View Article : Google Scholar
|
|
52
|
Eberhardt W, Huwiler A, Beck KF, Walpen S
and Pfeilschifter J: Amplification of IL-1 beta-induced matrix
metalloproteinase-9 expression by superoxide in rat glomerular
mesangial cells is mediated by increased activities of NF-kappa B
and activating protein-1 and involves activation of the
mitogen-activated protein kinase pathways. J Immunol.
165:5788–5797. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Im NK, Jang WJ, Jeong CH and Jeong GS:
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the
NF-κB activation through MAPK signaling pathways in MCF-7 human
breast carcinoma cells. J Med Food. 17:855–861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lin FY, Hsieh YH, Yang SF, Chen CT, Tang
CH, Chou MY, Chuang YT, Lin CW and Chen MK: Resveratrol suppresses
TPA-induced matrix metalloproteinase-9 expression through the
inhibition of MAPK pathways in oral cancer cells. J Oral Pathol
Med. Nov 17–2014.Epub ahead of print. PubMed/NCBI
|
|
55
|
Tong Q, Qing Y, Wu Y, Hu X, Jiang L and Wu
X: Dioscin inhibits colon tumor growth and tumor angiogenesis
through regulating VEGFR2 and AKT/MAPK signaling pathways. Toxicol
Appl Pharmacol. 281:166–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang W, Ren F, Wu Q, Jiang D, Li H and Shi
H: MicroRNA-497 suppresses angiogenesis by targeting vascular
endothelial growth factor A through the PI3K/AKT and MAPK/ERK
pathways in ovarian cancer. Oncol Rep. 32:2127–2133.
2014.PubMed/NCBI
|
